Enteric Softgel Capsules Market Report 2024 (Global Edition)

Global Enteric Softgel Capsules Market Report 2024 Market Size Split by Product (Gelatin Softgel Capsules, Vegetarian Softgel Capsules), by Raw Materia (Type-A Gelatin (Pork Skin), Type-B Gelatin (Ani...

Enteric Softgel Capsules Market Report Description

We have various report editions of Enteric Softgel Capsules Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Enteric Softgel Capsules Market Insights Video

Competitive Landscape of the Enteric softgel capsule market

The competitive landscape of the enteric softgel capsule market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established medicine manufacturers, specialized Pharmaceutical Companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

March 2024: An agreement has been inked by Lonza to purchase the Genentech manufacturing plant located in Vacaville, US, from Roche. By volume, the Vacaville (US) location is among the biggest biologics manufacturing facilities worldwide. With this acquisition, Lonza will be able to produce biologics on a big scale for use in mammalian therapeutics and greatly expand the reach of its facility network throughout the United States. (Source: https://www.lonza.com/news/2024-03-20-07-00) February 2018: To fulfill the growing demand for K-CAPS around the world, Caps Canada invested in a new 100,000-square-foot K-CAPS plant with an additional capsule production increase; this was roughly three times the amount Caps Canada invested in an HPMC capsule expansion. (Source: https://capscanada.com/news-events/capscanada-expands-k-caps-hpmc-capsules-manufacturing-capacity-for-second-time/)

Top Companies Market Share in Enteric Softgel Capsules Industry: (In no particular order of Rank)

• BASF SE
• Catalent
• Inc.
• Colorcon Inc.
• Fuji Capsules Co.
• Ltd.
• InovoBiologic Inc.
• NOW Foods Inc.
• Sirio Pharma Co.
• Ltd.
• Super Spectrim
• Thermo Fisher Scientific
• Inc. (Patheon)
• Trigen Laboratories
• Inc.
• Aenova Group
• ProCaps Laboratories
• InovoBiologic Inc.
• Lonza Group Ltd
• NOW Foods Inc.
• Nutranorth
• Kaustubha Herbal & nutri Care
• Vision Body Care Pvt. Ltd.
• B N Herbals
• United Laboratories
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Enteric softgel capsule market

Which Region Dominates the Enteric softgel capsule market in 2024?

According to cognitive market research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the high cost of healthcare per person in this area, growing investments in R&D to create new varieties, and growing consumer knowledge of wholesome supplements are all considered contributing factors to its growth. The North American market is dominated by large companies like Colocon Inc., which will support enteric softgel capsule demand in the upcoming years.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the enteric softgel capsule market due to several compelling reasons. The rising incidence of nutritional problems, the expanding healthcare sector, and the increase in government spending to build the infrastructure for healthcare are all factors contributing to the expansion of this region. Furthermore, it is anticipated that in the upcoming years, this region will generate a sizable amount of money due to the increased consumer knowledge of nutritional issues, prevention, and treatments.

 

The current report Scope analyzes Enteric Softgel Capsules Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Enteric Softgel Capsules Market

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1018.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.

• According to cognitive market research, the US had a major share in the enteric softgel capsule market with a market size of USD 803.27 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. Nutritional deficits and other conditions are becoming more prevalent. Enteric softgels provide a means of avoiding stomach acid and maximizing absorption by delivering vital nutrients straight to the colon.
• The Canada enteric softgel capsule market had a market share of USD 122.17 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Aging population in Canada, there is a growing need for vitamins and prescriptions that are easy for senior citizens to chew and digest. Enteric softgels provide a way to take drugs that could cause stomach irritation.
• The Mexico enteric softgel capsule market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 92.65 million in 2024.

Europe Enteric Softgel Capsules Market

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 763.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031

• The United Kingdom enteric softgel capsule market had a market share of USD 128.28 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. In the UK, the population is aging, and medicine needs are increasing with age. Because enteric softgel capsules are simpler to swallow than tablets and may lessen stomach discomfort, they may be an excellent choice for older persons.
• The France enteric softgel capsule market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 70.25 million in 2024.
• According to cognitive market research, the German enteric softgel capsule market size was valued at USD 151.18 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. In Germany, it serves as the center for the two main end markets for enteric capsules: the pharmaceutical and nutraceutical sectors. The demand for enteric softgel capsules will be directly impacted by the expansion of these industries.
• The Italy enteric softgel capsule market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 65.67 million in 2024.
• The Russia enteric softgel capsule market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 118.35 million in 2024.
• The Spain enteric softgel capsule market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 62.61 million in 2024
• The Luxembourg enteric softgel capsule market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 23.67 million in 2024.
• The Portugal enteric softgel capsule market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 16.03 million in 2024.
• The Greece enteric softgel capsule market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 9.16 million in 2024.
• Rest of Europe's enteric softgel capsule market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 118.35 million in 2024.

Asia Pacific Enteric Softgel Capsules Market

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 585.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031

• According to cognitive market research, the China enteric softgel capsule market size was valued at USD 263.43 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Chinese consumers are flocking to nutraceuticals for their health benefits and are becoming more interested in preventative healthcare.
• The Japan enteric softgel capsule market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 80.78 million in 2024.
• The India enteric softgel capsule market had a market share of USD 70.25 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In India, the market is being driven by a growing awareness of the advantages of enteric softgel capsules.
• The South Korean enteric softgel capsule market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 58.54 million in 2024.
• The Australia Enteric softgel capsule market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 30.44 107.06 million in 2024.
• The South East Asia Enteric softgel capsule market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 40.39 million in 2024.
• The Rest of the Asia Pacific Enteric softgel capsule market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 41.56 million in 2024.

South America Enteric Softgel Capsules Market

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 127.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031

• According to cognitive market research, the Brazil enteric softgel capsule market size was valued at USD 54.47 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Enteric capsules are widely used by the pharmaceutical and nutraceutical sectors in Brazil, which has a thriving life sciences sector.
• Argentina's enteric softgel capsule market had a market share of USD 21.38 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Enteric softgels for supplements may become popular as Argentinians place a high priority on preventative healthcare.
• Colombia's enteric softgel capsule market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 11.33 million in 2024.
• Peru Enteric softgel capsule market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 10.44 million in 2024.
• Chile Enteric softgel capsule market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 9.16 million in 2024.
• The Rest of Latin America Enteric softgel capsule market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 20.49 million in 2024.

Middle East and Africa Enteric Softgel Capsules Market

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 50.90 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• The GCC Countries' enteric softgel capsule market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 21.79 million in 2024. In the GCC countries, there is a growing consciousness of health and wellbeing to propel the industry.
• The Egypt Enteric softgel capsule market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 5.34 million in 2024.
• The South Africa Enteric softgel capsule market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 8.04 million in 2024. The South African government is driving the industry by investing in healthcare programs and infrastructure.
• The Turkey Enteric softgel capsule market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 4.38 million in 2024.
• The Nigeria Enteric softgel capsule market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 5.34 million in 2024.
• The Rest of the MEA Enteric softgel capsule market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 6.01 million in 2024.

Enteric Softgel Capsules Market Analysis

Enteric softgel capsule market Product Segment Analysis

According to cognitive market research, Gelatin Softgel Capsules stand out as the dominating category. Compared to non-gelatin alternatives, gelatin-based softgels have been around for a longer period. This leads to well-established production procedures, increased accessibility from different suppliers, and maybe reduced prices. A wide range of drugs and nutrients can be capsuled using gelatin because of its well-balanced set of qualities. It dissolves consistently, makes a flexible capsule, and is reasonably priced.

Vegetarian Softgel Capsules emerge as the fastest-growing category in the Enteric softgel capsule market. Vegetarian and vegan diets are becoming more and more popular, which has increased demand for meatless substitutes like vegetarian softgel capsules composed of plant-based ingredients like cellulose and starch. Vegetarian softgel capsules are in line with consumer preferences for natural products, which are growing in popularity. Vegetarian softgels are a good choice because several religions and ethical perspectives forbid eating animal products.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Enteric Softgel Capsules Industry. Request a Free Sample PDF!

Enteric softgel capsule market Raw Material Segment Analysis

According to cognitive market research, the dominating category is Type-B Gelatin (Animal Bones and Skin). When opposed to Type-A gelatin, which is usually derived from pig skin, Type-B gelatin is frequently less expensive to produce. Because of this, producers find it to be a desirable alternative, particularly in markets where prices are crucial. For certain uses, Type-A gelatin provides superior gelling qualities and stability; nevertheless, Type-B gelatin is enough for enteric softgel capsules. These capsules are not meant to disintegrate in the stomach but rather in the intestines. The qualities of type-B gelatin are suitable for this use.

The fastest-growing category in the enteric softgel capsule market is Type-A Gelatin (Pork Skin). Because pork skin is a widely accessible supply material, it is economical to create Type-A gelatin. Excellent gelling qualities are provided by type-A gelatin, which produces robust and stable capsules that are appropriate for enteric coating. Production is efficient since manufacturers have worked with Type-A gelatin for a long time.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Enteric Softgel Capsules Application Segment Analysis

According to cognitive market research, the dominating category is Health Supplements. Demand for supplements that improve general health is rising as people place more emphasis on wellness and preventative healthcare. Supplement use is made convenient and effortless with enteric softgels. In comparison to tablets or capsules, they are frequently simpler to swallow, tasteless, and odorless. Certain components can be better absorbed in the intestines by being shielded from stomach acid by enteric coatings. For certain vitamins, minerals, and other nutraceuticals, this is essential.

The fastest-growing category in the enteric softgel capsule market is Cough and Cold Preparations. Compared to tablets or capsules, softgels are simpler to swallow, which makes them the perfect choice for children or people who have trouble swallowing pills when taking a cough or cold remedies. Enzymatic coatings on the capsules minimize stomach irritation by ensuring the drug reaches the intestines, where it is absorbed. When it comes to cough and cold medicines, softgels make accurate pharmaceutical administration possible.

• Antacid & Antiflatulent Preparations
• Anti-inflammatory Drugs
• Antibiotic & Antibacterial Drugs
• Cough & Cold Preparations
• Health Supplements
• Vitamin & Dietary Supplements
• Other Therapeutic Applications

Enteric Softgel Capsules End User Segment Analysis

According to cognitive market research, the dominating category is Pharmaceutical Companies. Softgels with enteric coatings shield drugs from stomach acid so they can enter the intestine and be properly absorbed. For many medications, especially those that need to be administered to a specific site in the digestive system or can be affected by stomach acid, this regulated release is essential. Pharmaceutical companies are always coming up with fresh ideas and creating new drugs. Enteric softgels are a popular option because they provide a flexible and efficient delivery route for these innovative medications.

The fastest-growing category in the Enteric softgel capsule market is Nutraceutical Companies. People are paying more and more attention to general wellbeing and preventive healthcare. As a result, there is an increase in demand for nutraceutical goods, including vitamins and nutritional supplements. By avoiding the harsh, acidic environment of the stomach, they preserve some nutrients and improve absorption in the intestine. Because of their smooth texture and ease of swallowing, softgel capsules are more appealing than tablets or pills. This is a huge help to those who have trouble taking their medications.

• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Food Industry

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion